Methylphenidate XR (Aptensio)

What it isExtended-release dopamine and norepinephrine reuptake inhibitor (APTENSIO XR, 2015); ADHD.

Why this oneIts sprinklable capsule uses 40% IR / 60% DR beads and provides 8-12 h (Carlat Table 1) of action.

What limits itAbuse and dependence remain stimulant risks. Appetite loss, insomnia, and blood-pressure elevation often limit treatment.